Literature DB >> 16357448

Increased plasma levels of thioredoxin in patients with glucose intolerance.

Shinzo Miyamoto1, Hiroaki Kawano, Jun Hokamaki, Hirofumi Soejima, Sunao Kojima, Takashi Kudoh, Yasuhiro Nagayoshi, Seigo Sugiyama, Tomohiro Sakamoto, Michihiro Yoshimura, Hajime Nakamura, Junji Yodoi, Hisao Ogawa.   

Abstract

OBJECTIVE: The aim of the present study was to determine the effects of glucose intolerance on oxidative stress in patients with coronary artery disease (CAD).
METHODS: The patients were divided into 3 groups, diabetes mellitus (DM), IGT or normal glucose tolerance (NGT) according to the criteria of the American Diabetes Association. PATIENTS: The present study consisted of 178 consecutive patients who underwent diagnostic coronary arteriography and a 75-g glucose tolerance test.
RESULTS: The level of plasma thioredoxin, a marker of oxidative stress was measured in every patient during the fasting state. The levels of plasma thioredoxin were significantly higher in the DM and IGT groups than the NGT group. Furthermore, we found that there was a positive association between thioredoxin levels and glycosylated hemoglobin (sigma=0.225, p=0.018). In multivariate logistic regression analysis, glucose intolerance (DM or IGT) was only independently associated with the high levels of thioredoxin. The levels of plasma thioredoxin were significantly higher in the CAD group compared to the non-CAD group. In multivariate logistic regression analysis, high levels of thioredoxin, male, age and hypertension were independently associated with the presence of CAD.
CONCLUSION: Glucose intolerance was associated with the high levels of thioredoxin. High levels of thioredoxin were related to the presence of CAD. The measurement of thioredoxin as the marker of oxidative stress may be useful for monitoring the development of the cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357448     DOI: 10.2169/internalmedicine.44.1127

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

Review 1.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

2.  Treatments with sodium selenate or doxycycline offset diabetes-induced perturbations of thioredoxin-1 levels and antioxidant capacity.

Authors:  Mustafa Atalay; Ayca Bilginoglu; Tarja Kokkola; Niku Oksala; Belma Turan
Journal:  Mol Cell Biochem       Date:  2011-01-19       Impact factor: 3.396

Review 3.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 4.  Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.

Authors:  Md Kaimul Ahsan; Istvan Lekli; Diptarka Ray; Junji Yodoi; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

5.  Decreased thioredoxin-1 and increased HSP90 expression in skeletal muscle in subjects with type 2 diabetes or impaired glucose tolerance.

Authors:  M Venojärvi; A Korkmaz; S Aunola; K Hällsten; K Virtanen; J Marniemi; J-P Halonen; O Hänninen; P Nuutila; M Atalay
Journal:  Biomed Res Int       Date:  2014-02-04       Impact factor: 3.411

6.  Reduction of glucose intolerance with high fat feeding is associated with anti-inflammatory effects of thioredoxin 1 overexpression in mice.

Authors:  Adam B Salmon; Lisa C Flores; Yan Li; Holly Van Remmen; Arlan Richardson; Yuji Ikeno
Journal:  Pathobiol Aging Age Relat Dis       Date:  2012-05-17

7.  Singlet oxygen induced products of linoleates, 10- and 12-(Z,E)-hydroxyoctadecadienoic acids (HODE), can be potential biomarkers for early detection of type 2 diabetes.

Authors:  Aya Umeno; Mototada Shichiri; Noriko Ishida; Yoshiko Hashimoto; Kaori Abe; Masatoshi Kataoka; Kohzoh Yoshino; Yoshihisa Hagihara; Nanako Aki; Makoto Funaki; Yasuhiko Asada; Yasukazu Yoshida
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

8.  Thioredoxin interacting protein is a potential regulator of glucose and energy homeostasis in endogenous Cushing's syndrome.

Authors:  Tove Lekva; Jens Bollerslev; Afaf Sahraoui; Hanne Scholz; Hege Bøyum; Johan Arild Evang; Kristin Godang; Pål Aukrust; Thor Ueland
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

Review 9.  The role of lipid peroxidation in neurological disorders.

Authors:  Mototada Shichiri
Journal:  J Clin Biochem Nutr       Date:  2014-04-09       Impact factor: 3.114

Review 10.  Anti-Inflammatory Thioredoxin Family Proteins for Medicare, Healthcare and Aging Care.

Authors:  Junji Yodoi; Yoshiyuki Matsuo; Hai Tian; Hiroshi Masutani; Takashi Inamoto
Journal:  Nutrients       Date:  2017-09-29       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.